Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Company News
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Open Book Extracts
Open Book Extracts
Activities:
Ingredients
Trending Articles
38TERA launches dual-stage capsule for targeted bloating relief
BDR combines peppermint oil and probiotic yeast ibSium in a capsule-in-capsule delivery system designed to release the ingredients in different areas of the digestive tract
ThymoDream black cumin extract shows sleep benefits comparable to melatonin
Akay Bioactives’ ThymoDream improved sleep parameters and daytime sleepiness in a head-to-head trial comparing the plant-based ingredient with synthetic melatonin
Nutriventia secures investment to accelerate global nutraceutical expansion
Indian ingredients supplier Nutriventia will use new investment from NDude Labs to expand clinical R&D, its branded portfolio and US commercial operations
Rapid focus, no caffeine: new study confirms Zynamite delivers fast-acting benefits for cognition and mood
Fast-acting cognitive and mood benefits from water-soluble mango leaf extract
Nova Mentis launches precision-fermented hydroxytyrosol ingredient
Polyphenol-HT1 targets healthy ageing, cardiovascular and cellular health formulations with a high-purity, scalable production approach
Upcoming event
CPHI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all
Related Content
Ingredients
Open Book Extracts (OBX) announces founding membership in ONE HEMP
Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients
OBX launches trial for minor cannabinoid formulations
The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance
OBX receives strategic investment from Btomorrow Ventures
The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients
Open Book Extracts expands capabilities and management team to boost finished goods manufacturing
The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory
OBX announces results of Phase I toxicology assessment
The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients
OBX completes trial of cannabinoids for pain relief
Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients
Open Book Extracts appoints European sales leadership
In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now